$9.18
0.99% today
NYSE, Sep 19, 10:12 pm CET
ISIN
US87918A1051
Symbol
TDOC

Teladoc Inc Stock News

Neutral
GlobeNewsWire
2 months ago
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Teladoc Health, Inc. (NYSE: TDOC).
Neutral
PRNewsWire
2 months ago
NEW YORK , July 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Teladoc investors who were adversely affected by alleged securities fraud between November 2, 2022 and February 20, 2024.
Neutral
Accesswire
2 months ago
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / If you suffered a loss on your Teladoc Health, Inc. (NYSE:TDOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/teladoc-health-inc-lawsuit-submission-form?prid=90706&wire=1 or contact Joseph E. Levi, Esq.
Neutral
GlobeNewsWire
2 months ago
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Teladoc Health, Inc. (“Teladoc” or “the Company”) (NYSE: TDOC) and certain of its officers.
Neutral
Accesswire
2 months ago
NEW YORK, NY / ACCESSWIRE / July 14, 2024 / If you suffered a loss on your Teladoc Health, Inc. (NYSE:TDOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/teladoc-health-inc-lawsuit-submission-form?prid=90669&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
2 months ago
NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Teladoc Health Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Positive
The Motley Fool
2 months ago
Investors are showing varying degrees of appetite for the telehealth and diabetes care industries. Teladoc has undergone major changes in recent years, and investors are warily eyeing its path forward.
Neutral
Accesswire
2 months ago
NEW YORK, NY / ACCESSWIRE / July 13, 2024 / If you suffered a loss on your Teladoc Health, Inc. (NYSE:TDOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/teladoc-health-inc-lawsuit-submission-form?prid=90616&wire=1 or contact Joseph E. Levi, Esq.
Show more news

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today